VIJAYAWADA: Raja Yarlagadda Ankineedu Prasad Bahadur (86), son of Raja Siva Rama Prasad of the Challapalli Samasthanam, passed away on Friday at his residence in Coimbatore, Tamil Nadu.

Sanjeev Prasad of Kotak warns of overvaluation in Indian small and midcaps; says stocks are still a long way off 'fair value'. Written by Sumana Sarkar June 3, 2025 12:38 IST ...

On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic attention-seeker peddling misinformation, whose views will cost lives.

The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and US health agencies — to a key role within the Food and Drug Administration was ...

Five years ago, working in Portland, Dr. Vinay Prasad was throwing stones from the side of the road.Now he is behind the wheel — heading a pivotal science program for the Trump administration ...

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.

FDA Commissioner Marty Makary on Tuesday named Indian-origin hematologist oncologist Vinay Prasad as the next director of the Center for Biologics and Research. Sunday, Jun 22, 2025.

Controversial oncoologist-haematologist Vinay Prasad will be the FDA's top vaccine regulator. Apart from his extensive research and contribution in the field of oncology, he is known for his ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised concerns over regulatory scrutiny as the biotech market dropped.

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...